{"id":10385,"date":"2026-09-09T13:13:20","date_gmt":"2026-09-09T13:13:20","guid":{"rendered":"https:\/\/bristishpharmacy.co.uk\/?post_type=product&#038;p=10385"},"modified":"2026-09-16T09:37:00","modified_gmt":"2026-09-16T09:37:00","slug":"chelohart","status":"publish","type":"product","link":"https:\/\/bristishpharmacy.co.uk\/it\/shop\/chelohart\/","title":{"rendered":"Chelohart"},"content":{"rendered":"<h2 data-path-to-node=\"0\">1. Classification and Chemical Overview<\/h2>\n<p data-path-to-node=\"1\">Chelohart (frequently catalogued in scientific literature and international clinical compendia as peptide complex A-3 or cardiac peptide bioregulator, with synthetic analogues known as the cytogen peptide complex Lys-Glu-Asp or related cardiomyocyte-trophic oligopeptides) belongs to the cytomax class of organ-specific biological response modifiers. Chemically, the natural formulation comprises a purified, low-molecular-weight polypeptide fraction isolated from the myocardial tissue of young mammalian livestock, predominantly bovine donors (<i data-path-to-node=\"1\" data-index-in-node=\"546\">Bos taurus<\/i>). The extraction protocol utilises gentle acetic acid digestion coupled with sequential ultrafiltration to isolate polypeptide fractions with an upper molecular mass cut-off strictly restricted below <span class=\"math-inline\" data-math=\"5\\text{ to }10\\text{ kDa}\" data-index-in-node=\"757\">$5\\text{ to }10\\text{ kDa}$<\/span>. The biologically active fraction comprises ultra-short regulatory oligopeptides spanning 2 to 6 amino acid sequences, trace endogenous nucleopeptides, and tissue-specific cardiac regulatory signalling motifs. Synthetic counterparts reproduce targeted functional sequences chemically\u2014most commonly short di-, tri-, or tetrapeptide motifs\u2014using solid-phase peptide synthesis. The preparation is presented in hard gelatin or hydroxypropyl methylcellulose (HPMC) capsules containing standard pharmaceutical excipients, such as microcrystalline cellulose, lactose, and calcium stearate.<\/p>\n<p data-path-to-node=\"2\">Within the United Kingdom regulatory framework, Chelohart possesses no marketing authorisation (MA) from the Medicines and Healthcare products Regulatory Agency (MHRA). It is not catalogued in the British National Formulary (BNF) and is not scheduled as a Prescription Only Medicine (POM), Pharmacy (P) medicine, or General Sales List (GSL) drug under the Human Medicines Regulations 2012. Within the UK, this preparation is commercialised strictly as a non-medicinal food supplement or chemical research material governed by the Food Safety Act 1990 and the Nutrition and Health Claims (England) Regulations. In accordance with domestic trading standards and statutory food supplement legislation, commercial distributors are legally prohibited from articulating therapeutic or medicinal claims concerning the prevention, diagnosis, mitigation, or treatment of clinically established cardiovascular pathologies (such as acute coronary syndromes, myocardial infarction, chronic heart failure [HFpEF\/HFrEF], cardiac arrhythmias, hypertensive heart disease, myocarditis, or dilated cardiomyopathy).<\/p>\n<h2 data-path-to-node=\"3\">2. Mechanism of Action and Pharmacodynamics<\/h2>\n<p data-path-to-node=\"4\">The pharmacodynamic profile of Chelohart is rooted in the tissue-specific epigenetic model of short-chain peptide bioregulation, operating primarily via nuclear transactivation, metabolic optimization, and cellular homeostasis within working cardiomyocytes and the cardiac conduction system:<\/p>\n<ul data-path-to-node=\"5\">\n<li>\n<p data-path-to-node=\"5,0,0\"><b data-path-to-node=\"5,0,0\" data-index-in-node=\"0\">Epigenetic and Transcriptional Regulation:<\/b> Due to low molecular mass, compact hydrodynamic volume, and neutral-to-amphiphilic surface charges, the ultra-short oligopeptides in Chelohart cross coronary endothelial barriers and cardiomyocyte sarcolemmal membranes. They translocate across the nuclear pore complex into the nucleoplasm, where they bind site-specifically to complementary nucleotide sequences within the major and minor grooves of double-stranded genomic DNA and nucleosomal core histones. This interaction alters nucleosomal packaging, facilitates chromatin unwinding from transcriptionally inactive heterochromatin to open euchromatin, and recruits RNA polymerase II, modulating the transcription of structural and functional genes essential for myocardial cytoarchitecture and metabolic competence.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"5,1,0\"><b data-path-to-node=\"5,1,0\" data-index-in-node=\"0\">Contractile Apparatus and Cytoskeletal Homeostasis:<\/b> In vitro and animal models demonstrate that myocardial peptides stimulate the transcriptional synthesis of vital structural and contractile proteins, including cardiac alpha-actin (<i data-path-to-node=\"5,1,0\" data-index-in-node=\"233\">ACTC1<\/i>), beta-myosin heavy chain (<i data-path-to-node=\"5,1,0\" data-index-in-node=\"266\">MYH7<\/i>), and troponin complexes. Rather than acting as direct positive inotropes (such as cardiac glycosides or beta-agonists), these peptides appear to support intrinsic cellular protein synthetic machinery, facilitating structural micro-repair of sarcomeric units damaged by ischaemic or mechanical overload without raising myocardial oxygen consumption.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"5,2,0\"><b data-path-to-node=\"5,2,0\" data-index-in-node=\"0\">Mitochondrial Energetics and ATP Turnover:<\/b> Cardiomyocyte peptide bioregulators promote the functional maintenance of enzymes involved in mitochondrial oxidative phosphorylation and fatty acid beta-oxidation. They support mitochondrial membrane stability, maintain basal intracellular adenosine triphosphate (ATP) and phosphocreatine reserves, and improve efficiency of electron transport chain complexes under hypoxic conditions, aiding the preservation of excitation-contraction coupling without precipitating tachyarrhythmias.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"5,3,0\"><b data-path-to-node=\"5,3,0\" data-index-in-node=\"0\">Cytoprotection and Apoptosis Resistance:<\/b> Exposure to cardiac peptide fractions reduces myocardial cell death induced by oxidative stress, hypoxia-reoxygenation injury, or neurohormonal overdrive (e.g., persistent catecholamine exposure). This cytoprotective action is mediated by downregulating pro-apoptotic executioners (caspase-3 and Bax), preserving mitochondrial inner membrane integrity (<span class=\"math-inline\" data-math=\"\\Delta\\Psi_m\" data-index-in-node=\"394\">$\\Delta\\Psi_m$<\/span>), and transcriptionally upregulating endogenous enzymatic antioxidants, notably superoxide dismutase (SOD) and glutathione peroxidase within cardiac tissues.<\/p>\n<\/li>\n<\/ul>\n<h2 data-path-to-node=\"6\">3. Approved UK Clinical Indications and Therapeutic Scope<\/h2>\n<p data-path-to-node=\"7\">Chelohart possesses no approved clinical indications in the United Kingdom. No randomized, double-blind, multicentre clinical trials meeting the statutory criteria of the MHRA have been conducted to establish clinical efficacy, therapeutic reproducibility, or cardiovascular toxicological safety profiles.<\/p>\n<p data-path-to-node=\"8\">The National Institute for Health and Care Excellence (NICE) does not endorse, recommend, or integrate Chelohart into any formal clinical pathway. It is entirely absent from clinical guidelines governing acute coronary syndromes (NG185), chronic heart failure in adults: diagnosis and management (NG106), hypertension in adults: diagnosis and management (NG136), and arrhythmias\/atrial fibrillation (NG196).<\/p>\n<p data-path-to-node=\"9\">The application of Chelohart is confined strictly to non-clinical consumer wellness contexts and preliminary laboratory research. In exploratory literature and private functional health sectors, it is investigated for:<\/p>\n<ul data-path-to-node=\"10\">\n<li>\n<p data-path-to-node=\"10,0,0\">Supporting functional physiological resilience of the cardiovascular system during non-pathological, age-related cardiovascular decline.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"10,1,0\">Complementary nutritional support during convalescence following prolonged athletic conditioning, strenuous physical overexertion, or high-altitude exposure.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"10,2,0\">Maintenance of baseline myocardial energetic efficiency and microvascular capillary reserve in ageing cohorts.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"10,3,0\">Preclinical animal models examining left ventricular architecture preservation, reduction of interstitial myocardial fibrosis, and electrical stability under experimental ischaemic or pressure-overload conditions.<\/p>\n<\/li>\n<\/ul>\n<p data-path-to-node=\"11\">Chelohart holds no status within the NHS drug tariff, cannot be prescribed on NHS prescription forms (FP10), and must never replace validated clinical treatments, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor-neprilysin inhibitors (ARNIs), beta-adrenoceptor blockers, mineralocorticoid receptor antagonists (MRAs), sodium-glucose co-transporter-2 (SGLT2) inhibitors, antiplatelet therapies, or acute revascularisation (percutaneous coronary intervention or CABG).<\/p>\n<h2 data-path-to-node=\"12\">4. Pharmacokinetic Profile and Metabolic Fate<\/h2>\n<p data-path-to-node=\"13\">Because Chelohart is formulated as an oral capsule, its pharmacokinetic disposition is determined by gastrointestinal transport and physiological peptide clearance kinetics:<\/p>\n<ul data-path-to-node=\"14\">\n<li>\n<p data-path-to-node=\"14,0,0\"><b data-path-to-node=\"14,0,0\" data-index-in-node=\"0\">Absorption:<\/b> Crude protein macromolecules undergo extensive cleavage in the stomach by pepsin and in the small intestine by pancreatic endopeptidases (trypsin, chymotrypsin). However, the ultra-short di-, tri-, and tetrapeptides present in Chelohart exhibit structural resistance to complete brush-border aminopeptidase degradation. These intact short peptide sequences cross the apical enterocyte membrane into the portal circulation via the low-affinity, high-capacity proton-coupled peptide transporter 1 (PEPT1). Peak plasma concentrations (<span class=\"math-inline\" data-math=\"T_{max}\" data-index-in-node=\"544\">$T_{max}$<\/span>) of intact circulating oligopeptides typically occur within 20 to 50 minutes following oral ingestion.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"14,1,0\"><b data-path-to-node=\"14,1,0\" data-index-in-node=\"0\">Distribution:<\/b> Following mesenteric absorption and portal transit, the peptides enter the systemic vascular compartment. With a low molecular weight and hydrophilic properties, the apparent volume of distribution (<span class=\"math-inline\" data-math=\"V_d\" data-index-in-node=\"213\">$V_d$<\/span>) corresponds closely to total extracellular fluid volume. Preclinical biodistribution assays demonstrate selective tropism toward myocardial tissue, crossing coronary capillaries to access the myocardial interstitial space, sarcolemma, and nuclear compartments of cardiomyocytes. Plasma protein binding is negligible (<span class=\"math-inline\" data-math=\"&lt;5\\%\" data-index-in-node=\"535\">$&lt;5\\%$<\/span>).<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"14,2,0\"><b data-path-to-node=\"14,2,0\" data-index-in-node=\"0\">Biotransformation:<\/b> Chelohart does not undergo hepatic clearance via the cytochrome P450 (CYP450) microsomal monooxygenase system (e.g., CYP1A2, CYP2D6, CYP3A4). Systemic clearance is mediated entirely by circulating plasma aminopeptidases, carboxypeptidases, and cellular endopeptidases, which rapidly hydrolyse peptide bonds into native constituent individual L-amino acids (such as L-alanine, L-glutamic acid, and L-aspartic acid). These amino acids enter endogenous amino acid turnover and protein synthesis pools.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"14,3,0\"><b data-path-to-node=\"14,3,0\" data-index-in-node=\"0\">Elimination:<\/b> Systemic elimination of intact peptides is rapid, with an effective half-life (<span class=\"math-inline\" data-math=\"t_{1\/2}\" data-index-in-node=\"92\">$t_{1\/2}$<\/span>) ranging between 15 and 60 minutes. Direct renal excretion of intact macromolecular peptides is negligible; end-stage metabolites are cleared as urinary urea, with trace carbon atoms exhaled as carbon dioxide via respiratory gas exchange.<\/p>\n<\/li>\n<\/ul>\n<h2 data-path-to-node=\"15\">5. Physiological Effects and Adverse Event Spectrum<\/h2>\n<p data-path-to-node=\"16\">The primary physiological effect documented in preclinical investigations is the normalization of myocardial contractile function, characterized by maintained stroke volume under metabolic stress, preservation of left ventricular ejection fraction (LVEF) during experimental ischaemia, reduction of myocardial lipid peroxidation, and modulation of myocardial collagen turnover to prevent pathological extracellular matrix remodeling. In animal models of experimental hypertension or focal ischaemia, these agents demonstrate structural maintenance of myofibrillar orientation, preserved capillary-to-myocyte ratios, and electrical membrane stabilization without producing negative or positive dromotropic or inotropic abnormalities.<\/p>\n<p data-path-to-node=\"17\">Because Chelohart has not undergone structured, large-scale Phase I\u2013IV clinical pharmacovigilance surveillance, documentation of adverse drug reactions is derived primarily from observational cohorts and preclinical animal toxicology:<\/p>\n<ul data-path-to-node=\"18\">\n<li>\n<p data-path-to-node=\"18,0,0\"><b data-path-to-node=\"18,0,0\" data-index-in-node=\"0\">Very Common (<span class=\"math-inline\" data-math=\"\\ge 1\/10\" data-index-in-node=\"13\">$\\ge 1\/10$<\/span>):<\/b> None documented in clinical literature.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"18,1,0\"><b data-path-to-node=\"18,1,0\" data-index-in-node=\"0\">Common (<span class=\"math-inline\" data-math=\"1\/100\" data-index-in-node=\"8\">$1\/100$<\/span> to <span class=\"math-inline\" data-math=\"&lt;1\/10\" data-index-in-node=\"17\">$&lt;1\/10$<\/span>):<\/b> Mild, self-limiting gastrointestinal symptoms following oral intake, including transient nausea, epigastric fullness, mild dyspepsia, and abdominal bloating.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"18,2,0\"><b data-path-to-node=\"18,2,0\" data-index-in-node=\"0\">Uncommon (<span class=\"math-inline\" data-math=\"1\/1,000\" data-index-in-node=\"10\">$1\/1,000$<\/span> to <span class=\"math-inline\" data-math=\"&lt;1\/100\" data-index-in-node=\"21\">$&lt;1\/100$<\/span>):<\/b> Transient sensations of mild cephalalgia; mild, localized cutaneous pruritus or macular rash; transient sensations of mild palpitations or subjective chest awareness.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"18,3,0\"><b data-path-to-node=\"18,3,0\" data-index-in-node=\"0\">Rare (<span class=\"math-inline\" data-math=\"1\/10,000\" data-index-in-node=\"6\">$1\/10,000$<\/span> to <span class=\"math-inline\" data-math=\"&lt;1\/1,000\" data-index-in-node=\"18\">$&lt;1\/1,000$<\/span>):<\/b> Type I immediate allergic hypersensitivity reactions (urticaria, angioedema, or bronchospasm), principally triggered in atopic individuals sensitized to bovine structural protein residues.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"18,4,0\"><b data-path-to-node=\"18,4,0\" data-index-in-node=\"0\">Biological and Diagnostic Hazards:<\/b> Unregulated preparations derived from non-certified mammalian sources carry theoretical risks of transmissible spongiform encephalopathies (TSE\/BSE) if origin verification is absent. Crucially, self-administering unlicensed bioregulators to manage progressive exertional chest pain, breathlessness, peripheral oedema, or syncope presents a critical clinical hazard by potentially delaying diagnostic evaluation for acute myocardial infarction, unstable angina, severe valvular heart disease, high-grade conduction block, or life-threatening ventricular arrhythmias.<\/p>\n<\/li>\n<\/ul>\n<h2 data-path-to-node=\"19\">6. Contraindications, Drug Interactions, and Clinical Precautions<\/h2>\n<p data-path-to-node=\"20\">The handling and administration of Chelohart require strict adherence to fundamental cardiovascular, emergency, and pharmacological safety parameters:<\/p>\n<ul data-path-to-node=\"21\">\n<li>\n<p data-path-to-node=\"21,0,0\"><b data-path-to-node=\"21,0,0\" data-index-in-node=\"0\">Contraindications:<\/b><\/p>\n<ul data-path-to-node=\"21,0,1\">\n<li>\n<p data-path-to-node=\"21,0,1,0,0\">Documented hypersensitivity or history of allergic anaphylaxis to bovine-derived biological substances, gelatin, or any formulation excipients.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,0,1,1,0\">Acute coronary syndromes and acute myocardial infarction: Absolute contraindication as a therapeutic option; acute coronary occlusions require immediate emergency medical admission, emergency coronary angiography, dual antiplatelet therapy, anticoagulation, and revascularisation.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,0,1,2,0\">Severe decompensated heart failure (NYHA Class IV): Absolute contraindication as a self-care measure; severe pulmonary congestion, cardiogenic shock, and severe systemic fluid overload require specialist inpatient medical management and intravenous therapies.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,0,1,3,0\">Life-threatening cardiac arrhythmias: Contraindicated in patients with sustained ventricular tachycardia, ventricular fibrillation, acute atrial fibrillation with rapid ventricular response, or high-grade atrioventricular (AV) block.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,0,1,4,0\">Pregnancy and lactation: Absolute contraindication due to an absence of embryotoxicity, teratogenicity, and developmental reproductive safety data, alongside unknown secretion into human breast milk.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,0,1,5,0\">Paediatric population: Contraindicated in infants, children, and adolescents under 18 years due to an absence of safety and developmental data in the maturing paediatric cardiovascular system.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p data-path-to-node=\"21,1,0\"><b data-path-to-node=\"21,1,0\" data-index-in-node=\"0\">Drug Interactions:<\/b><\/p>\n<ul data-path-to-node=\"21,1,1\">\n<li>\n<p data-path-to-node=\"21,1,1,0,0\">Cardioprotective Prescription Medications (e.g., beta-blockers, ACE inhibitors, ARBs, ARNIs, calcium channel blockers, digoxin): No direct pharmacokinetic interactions via CYP450 enzymes have been documented; however, patients must not reduce, modify, or discontinue their prescribed cardiovascular regimens in favor of unlicensed peptide bioregulators.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,1,1,1,0\">Anticoagulants and Antiplatelets (e.g., warfarin, direct oral anticoagulants [DOACs], clopidogrel, aspirin): Concomitant administration is not known to alter coagulation factor synthesis or platelet aggregation parameters directly, but clinical surveillance remains standard practice.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,1,1,2,0\">Cytochrome P450 interactions: There are no documented pharmacokinetic induction or inhibition interactions with hepatic CYP450 isoenzymes.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p data-path-to-node=\"21,2,0\"><b data-path-to-node=\"21,2,0\" data-index-in-node=\"0\">Clinical Precautions:<\/b><\/p>\n<ul data-path-to-node=\"21,2,1\">\n<li>\n<p data-path-to-node=\"21,2,1,0,0\">Cardiovascular Alarm Symptoms (&#8220;Red Flags&#8221;): Patients presenting with red flag cardiovascular symptoms\u2014such as central crushing chest tightness radiating to the left arm or jaw, acute unexplained shortness of breath, sudden palpitations associated with presyncope or syncope, or rapid-onset bilateral pedal oedema\u2014mandate immediate emergency 999\/A&amp;E attendance rather than self-directed supplementation.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,2,1,1,0\">Cardiovascular Diagnostic Workup: Individuals experiencing persistent exertional breathlessness, fatigue, or reduced exercise tolerance require formal clinical evaluation\u2014including 12-lead electrocardiography (ECG), serum N-terminal pro-B-type natriuretic peptide (NT-proBNP), transthoracic echocardiography, and ambulatory cardiac rhythm monitoring\u2014prior to exploring non-medicinal products.<\/p>\n<\/li>\n<li>\n<p data-path-to-node=\"21,2,1,2,0\">Source Purity: Clinicians and researchers must verify that natural mammalian extracts possess documented batch-specific certification confirming extraction from BSE-free herds and compliance with UK\/EU biological safety criteria.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"excerpt":{"rendered":"<p>Unlicensed peptide complex derived from myocardial tissue, investigated for epigenetic modulation and cellular homeostasis of working cardiomyocytes.<\/p>","protected":false},"featured_media":10446,"comment_status":"open","ping_status":"closed","template":"","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""}},"product_brand":[],"product_cat":[793],"product_tag":[828],"class_list":["post-10385","product","type-product","status-publish","has-post-thumbnail","product_cat-accessories","product_tag-chelohart","instock","shipping-taxable","purchasable","product-type-simple"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.5 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Chelohart<\/title>\n<meta name=\"description\" content=\"Unlicensed peptide complex derived from myocardial tissue, investigated for epigenetic modulation and cellular homeostasis of working cardiomyocytes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bristishpharmacy.co.uk\/it\/shop\/chelohart\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chelohart\" \/>\n<meta property=\"og:description\" content=\"Unlicensed peptide complex derived from myocardial tissue, investigated for epigenetic modulation and cellular homeostasis of working cardiomyocytes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bristishpharmacy.co.uk\/it\/shop\/chelohart\/\" \/>\n<meta property=\"og:site_name\" content=\"British Pharmacy\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-16T09:37:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/photo_5125505188574727323_x.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/\",\"name\":\"Chelohart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5125505188574727323_x.jpg\",\"datePublished\":\"2026-09-09T13:13:20+00:00\",\"dateModified\":\"2026-09-16T09:37:00+00:00\",\"description\":\"Unlicensed peptide complex derived from myocardial tissue, investigated for epigenetic modulation and cellular homeostasis of working cardiomyocytes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5125505188574727323_x.jpg\",\"contentUrl\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5125505188574727323_x.jpg\",\"width\":600,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/chelohart\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/shop\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Chelohart\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/\",\"name\":\"British Pharmacy\",\"description\":\"Order Medication &amp; Pills Online\",\"publisher\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#organization\",\"name\":\"British Pharma\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Site-icon.png\",\"contentUrl\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Site-icon.png\",\"width\":513,\"height\":513,\"caption\":\"British Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/bristishpharmacy.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Chelohart","description":"Unlicensed peptide complex derived from myocardial tissue, investigated for epigenetic modulation and cellular homeostasis of working cardiomyocytes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bristishpharmacy.co.uk\/it\/shop\/chelohart\/","og_locale":"it_IT","og_type":"article","og_title":"Chelohart","og_description":"Unlicensed peptide complex derived from myocardial tissue, investigated for epigenetic modulation and cellular homeostasis of working cardiomyocytes.","og_url":"https:\/\/bristishpharmacy.co.uk\/it\/shop\/chelohart\/","og_site_name":"British Pharmacy","article_modified_time":"2026-09-16T09:37:00+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/photo_5125505188574727323_x.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"9 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/","url":"https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/","name":"Chelohart","isPartOf":{"@id":"https:\/\/bristishpharmacy.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/#primaryimage"},"image":{"@id":"https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/#primaryimage"},"thumbnailUrl":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/photo_5125505188574727323_x.jpg","datePublished":"2026-09-09T13:13:20+00:00","dateModified":"2026-09-16T09:37:00+00:00","description":"Unlicensed peptide complex derived from myocardial tissue, investigated for epigenetic modulation and cellular homeostasis of working cardiomyocytes.","breadcrumb":{"@id":"https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/#primaryimage","url":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/photo_5125505188574727323_x.jpg","contentUrl":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/photo_5125505188574727323_x.jpg","width":600,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/bristishpharmacy.co.uk\/shop\/chelohart\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bristishpharmacy.co.uk\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/bristishpharmacy.co.uk\/shop\/"},{"@type":"ListItem","position":3,"name":"Chelohart"}]},{"@type":"WebSite","@id":"https:\/\/bristishpharmacy.co.uk\/#website","url":"https:\/\/bristishpharmacy.co.uk\/","name":"British Pharmacy","description":"Order Medication &amp; Pills Online","publisher":{"@id":"https:\/\/bristishpharmacy.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bristishpharmacy.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/bristishpharmacy.co.uk\/#organization","name":"British Pharma","url":"https:\/\/bristishpharmacy.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/bristishpharmacy.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/Site-icon.png","contentUrl":"https:\/\/bristishpharmacy.co.uk\/wp-content\/uploads\/2026\/09\/Site-icon.png","width":513,"height":513,"caption":"British Pharma"},"image":{"@id":"https:\/\/bristishpharmacy.co.uk\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/product\/10385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/comments?post=10385"}],"version-history":[{"count":3,"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/product\/10385\/revisions"}],"predecessor-version":[{"id":10638,"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/product\/10385\/revisions\/10638"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/media\/10446"}],"wp:attachment":[{"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/media?parent=10385"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/product_brand?post=10385"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/product_cat?post=10385"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/bristishpharmacy.co.uk\/it\/wp-json\/wp\/v2\/product_tag?post=10385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}